SCHEMBL31340871

SCHEMBL31340871

CCOC(=O)c1cnc(Cl)nc1NC1CC[Si](C)(C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR2F2 P24468 2/20 0.51
▸ NPSR1 Q6W5P4 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ MEN1 O00255 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ S1PR2 O95136 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ XBP1 P17861 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ PPP1CA P62136 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ SYK P43405 4/20 0.49
▸ PDE4B Q07343 5/20 0.44
▸ JAK1 P23458 4/20 0.42
▸ JAK3 P52333 4/20 0.42
▸ POLB P06746 1/20 0.42
▸ FOS P01100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10050288 0.91 NR2F2 (0.56) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL4070421 0.89 NR2F2 (0.62) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL761164 0.89 NR2F2 (0.60) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL29501978 0.87 NR2F2 (0.63) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL20299361 0.87 NR2F2 (0.63) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL23452672 0.86 NR2F2 (0.53) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL20329838 0.86 NR2F2 (0.53) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL30736374 0.86 NR2F2 (0.53) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL20299341 0.86 NR2F2 (0.53) NR2F2NPSR1KDM4EMAPTMAPK1
SCHEMBL23620674 0.85 NR2F2 (0.52) NR2F2NPSR1KDM4EMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025049247-A1 5,6-CORE SILACYCLE BASED INHIBITORS OF DNA-DEPENDENT PROTEIN KINASE AND COMPOSITIONS AND APPLICATION IN GENE EDITING JUNO THERAPEUTICS, INC. (US) 2025-03-06 — — WO disclosed
Send feedback